Elevance Health, Inc. $ELV Shares Purchased by Wealthfront Advisers LLC

Wealthfront Advisers LLC grew its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 122.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 35,042 shares of the company’s stock after buying an additional 19,292 shares during the period. Wealthfront Advisers LLC’s holdings in Elevance Health were worth $11,323,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Physician Wealth Advisors Inc. boosted its position in Elevance Health by 331.6% during the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock worth $26,000 after acquiring an additional 63 shares during the last quarter. Activest Wealth Management lifted its stake in Elevance Health by 66.7% in the 3rd quarter. Activest Wealth Management now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 34 shares in the last quarter. Vermillion & White Wealth Management Group LLC lifted its stake in Elevance Health by 94.9% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock worth $30,000 after purchasing an additional 37 shares in the last quarter. BOK Financial Private Wealth Inc. purchased a new stake in shares of Elevance Health in the second quarter valued at approximately $32,000. Finally, Motco increased its holdings in shares of Elevance Health by 334.8% in the third quarter. Motco now owns 100 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares during the last quarter. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. TD Cowen reissued a “buy” rating on shares of Elevance Health in a research note on Wednesday, November 26th. Zacks Research raised shares of Elevance Health from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. UBS Group set a $400.00 price objective on shares of Elevance Health in a research report on Thursday, January 29th. Mizuho set a $413.00 target price on shares of Elevance Health in a research note on Friday, January 9th. Finally, Morgan Stanley dropped their price target on shares of Elevance Health from $359.00 to $352.00 and set an “equal weight” rating for the company in a research note on Wednesday, December 17th. Twelve research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $390.55.

Elevance Health Trading Down 0.6%

Shares of ELV stock opened at $325.61 on Wednesday. Elevance Health, Inc. has a 1-year low of $273.71 and a 1-year high of $458.75. The firm has a market cap of $71.87 billion, a PE ratio of 12.96, a price-to-earnings-growth ratio of 1.82 and a beta of 0.50. The company has a 50-day moving average of $351.86 and a two-hundred day moving average of $331.28. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.54 and a quick ratio of 1.56.

Elevance Health (NYSE:ELV) last released its quarterly earnings results on Wednesday, January 28th. The company reported $3.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.10 by $0.23. The business had revenue of $49.31 billion for the quarter, compared to the consensus estimate of $49.52 billion. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The business’s revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm earned $3.84 EPS. Elevance Health has set its FY 2026 guidance at 25.500- EPS. On average, analysts predict that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th will be given a dividend of $1.72 per share. This is an increase from Elevance Health’s previous quarterly dividend of $1.71. This represents a $6.88 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Tuesday, March 10th. Elevance Health’s dividend payout ratio (DPR) is 27.23%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.